View Discovery

Clinical Pipeline

Trials for Market Approval Download PPT

Pre-Clinical (GLP)


TB Alliance, Institute of Materia Medica
TB Alliance, Janssen Research & Development, LLC
iM4TB - Innovative Medicines for Tuberculosis
University of Munich, Hans-Knöll Institute, Jena, German Center for Infection Research (DZIF)
Microbiotix, Inc.

Phase 1


TB Alliance
Qurient Co., Ltd, Qurient Co. Ltd. / LLC "Infectex", a portfolio firm of Maxwell Biotech Venture Fund
GlaxoSmithKline
Otsuka Pharmaceutical Development & Commercialization, Inc.
Institute of Materia Medica

Phase 2


Sequella, Inc
The Aurum Institute NPC, Calibr, The Scripps Research Institute
Sequella, Inc
LegoChem
Nearmedic Plus LLC
NIAID, NIH, DHHS, Bill & Melinda Gates Foundation, EDCTP
Médecins Sans Frontières
CDC TBTC, NIAID, NIH, DHHS, Boston University
PanACEA, EDCTP, NIAID, NIH, DHHS, USAID
Medecins Sans Frontieres, The Netherlands
Weill Medical College of Cornell University